The Potential Predictive Biomarkers for Advanced Hepatocellular Carcinoma Treated With Anti-Angiogenic Drugs in Combination With PD-1 Antibody

The Potential Predictive Biomarkers for Advanced Hepatocellular Carcinoma Treated With Anti-Angiogenic Drugs in Combination With PD-1 Antibody

BackgroundBased on molecular biomarkers, anti-angiogenic drugs in combination with programmed cell death protein 1 (PD-1) antibodies can screen the potentially beneficial populations with hepatocellular carcinoma (HCC) and predict the efficacy after treatment. Therefore, we aimed to study predictive...

Full description

Bibliographic Details
Main Authors: Chenxi Liu, Sihui Zhu, Yanbing Dong, Jie Shao, Baorui Liu, Jie Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
hepatocellular carcinoma
neoantigen reactive T cells
immunotherapy
PD-1 antibody
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.930096/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.930096/full

Similar Items